Ethynerone (original) (raw)
Ethynerone (INN, USAN), also known as 17α-(2-chloroethynyl)estra-4,9-dien-17β-ol-3-one, is a steroidal progestin of the 19-nortestosterone group that was first reported in 1961 but was never marketed. Under the developmental code name MK-665, it was studied in combination with mestranol as an oral contraceptive. Development of the drug was discontinued due to concerns surrounding toxicity findings in dogs. It is a derivative of norethisterone.
| Property | Value |
|---|---|
| dbo:abstract | Ethynerone (INN, USAN), also known as 17α-(2-chloroethynyl)estra-4,9-dien-17β-ol-3-one, is a steroidal progestin of the 19-nortestosterone group that was first reported in 1961 but was never marketed. Under the developmental code name MK-665, it was studied in combination with mestranol as an oral contraceptive. Development of the drug was discontinued due to concerns surrounding toxicity findings in dogs. It is a derivative of norethisterone. In 1966, during its clinical development, ethynerone was found to produce mammary gland tumors in dogs treated with it at very high doses for prolonged periods of time. Subsequent investigation found that 17α-hydroxyprogesterone derivatives included anagestone acetate, chlormadinone acetate, medroxyprogesterone acetate, and megestrol acetate produced similar mammary gland tumors, and that their ability to do so correlated directly with their progestogenic actions. In contrast, the non-halogenated 19-nortestosterone derivatives norgestrel, norethisterone, noretynodrel, and etynodiol diacetate, which are much less potent as progestogens, did not produce such effects at the dosages tested. Clinical development of ethynerone was discontinued, and many of the 17α-hydroxyprogesterone derivatives were withdrawn for the indication of hormonal contraception. Research later on revealed species differences between dogs and humans and established that there is no similar risk in humans. (en) |
| dbo:casNumber | 3124-93-4 |
| dbo:fdaUniiCode | CKM4S0R7LX |
| dbo:pubchem | 18403 |
| dbo:thumbnail | wiki-commons:Special:FilePath/Ethynerone.svg?width=300 |
| dbo:wikiPageID | 49039976 (xsd:integer) |
| dbo:wikiPageLength | 6275 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1084543538 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Progestin dbc:Estranes dbc:Organochlorides dbc:Progestogens dbr:Combined_oral_contraceptive_pill dbr:Anagestone_acetate dbr:Medroxyprogesterone_acetate dbr:Megestrol_acetate dbr:Oral_administration dbr:Mammary_gland dbr:Steroid dbr:Combination_drug dbr:Clinical_development dbr:Hormonal_contraception dbr:Tumor dbr:Etynodiol_diacetate dbr:File:Progestin-induced_tumors_in_beagle_dogs.png dbr:Norethisterone dbr:Noretynodrel dbr:Norgestrel dbr:International_Nonproprietary_Name dbr:Chlormadinone_acetate dbr:Chloroethynylnorgestrel dbr:Mestranol dbr:United_States_Adopted_Name dbr:19-nortestosterone dbr:17α-hydroxyprogesterone dbr:Chloroethynyl dbr:File:Ethynerone_synthesis.svg |
| dbp:c | 20 (xsd:integer) |
| dbp:casNumber | 3124 (xsd:integer) |
| dbp:chemspiderid | 8512249 (xsd:integer) |
| dbp:cl | 1 (xsd:integer) |
| dbp:h | 23 (xsd:integer) |
| dbp:iupacName | -17 (xsd:integer) |
| dbp:o | 2 (xsd:integer) |
| dbp:pubchem | 18403 (xsd:integer) |
| dbp:routesOfAdministration | dbr:Oral_administration |
| dbp:smiles | CC12CCC3=C4CCCC=C4CCC3C1CCC2O (en) |
| dbp:stdinchi | 1 (xsd:integer) |
| dbp:stdinchikey | KEOBKPHJNAILCW-FUMNGEBKSA-N (en) |
| dbp:unii | CKM4S0R7LX (en) |
| dbp:width | 250 (xsd:integer) |
| dbp:wikiPageUsesTemplate | dbt:Clear dbt:Drugbox dbt:Genito-urinary-drug-stub dbt:Progesterone_receptor_modulators dbt:Reflist dbt:Short_description dbt:Steroid-stub dbt:Fdacite dbt:US_Patent |
| dcterms:subject | dbc:Estranes dbc:Organochlorides dbc:Progestogens |
| gold:hypernym | dbr:Progestin |
| rdf:type | owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug |
| rdfs:comment | Ethynerone (INN, USAN), also known as 17α-(2-chloroethynyl)estra-4,9-dien-17β-ol-3-one, is a steroidal progestin of the 19-nortestosterone group that was first reported in 1961 but was never marketed. Under the developmental code name MK-665, it was studied in combination with mestranol as an oral contraceptive. Development of the drug was discontinued due to concerns surrounding toxicity findings in dogs. It is a derivative of norethisterone. (en) |
| rdfs:label | Ethynerone (en) |
| owl:sameAs | yago-res:Ethynerone wikidata:Ethynerone https://global.dbpedia.org/id/2MtPR |
| prov:wasDerivedFrom | wikipedia-en:Ethynerone?oldid=1084543538&ns=0 |
| foaf:depiction | wiki-commons:Special:FilePath/Ethynerone.svg wiki-commons:Special:FilePath/Ethynerone_synthesis.svg wiki-commons:Special:FilePath/Progestin-induced_tumors_in_beagle_dogs.png |
| foaf:isPrimaryTopicOf | wikipedia-en:Ethynerone |
| is dbo:wikiPageRedirects of | dbr:Etynerone dbr:Ethyerone dbr:MK-665 dbr:MK665 dbr:MK_665 |
| is dbo:wikiPageWikiLink of | dbr:Etynerone dbr:Anagestone_acetate dbr:Ethyerone dbr:Chlormadinone_acetate dbr:Chloroethynylnorgestrel dbr:List_of_drugs:_Et dbr:MK-665 dbr:MK665 dbr:MK_665 |
| is foaf:primaryTopic of | wikipedia-en:Ethynerone |
